Image (961973db B7ab 40fa Ad75 4163738def9b 565 2)
Topiramate Tablet, Film Coated
Product Images NDC 60760-952
5 FDA label images from St. Mary's Medical Park Pharmacy · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 60760-952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Chemical structure diagram of topiramate, showing its molecular framework as depicted in the product data for the 50 mg oral tablet by St. Mary's Medical Park Pharmacy.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
A cumulative rate chart showing time to first seizure in days for patients taking topiramate at doses of 50 mg/day and 400 mg/day. The x-axis represents time in days up to 500, and the y-axis represents cumulative rates up to 0.50. The graph compares two patient groups with sample sizes of 234 and 236, respectively.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
A bar graph showing the change from baseline to double-blind phase in average monthly migraine period rate (±SE) for placebo and three doses of topiramate (50 mg/day, 100 mg/day, 200 mg/day) across two studies. The graph indicates increasing reduction in migraine rates with higher doses of topiramate compared to placebo, with statistical significance marked at p < 0.010 and p < 0.001 levels.*
952-60 (Topiramate 50mg 60ct 60760 952 60)
Topiramate 50 mg film-coated tablets packaging label showing 60 tablets per package. Manufactured by Unichem Laboratories LTD, India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes dosage form, strength, storage instructions at 20-25°C, and pharmacist dispensing cautions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
